Release Date: 27/08/10 18:22 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 91.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%